PMAG President Nana Samuel A. Tobbin Urges Heightened Pharmaceutical Standards Amid Flooding to Protect Public Health

The Pharmaceutical Manufacturers Association of Ghana (PMAG) has issued a critical call to its member companies to maintain rigorous quality standards to prevent the contamination of pharmaceutical products. This directive comes in response to recent flooding incidents across the country that have raised significant concerns regarding the integrity and safety of the national medicine supply. PMAG President Nana Samuel A. Tobbin emphasized that pharmaceutical security is a fundamental pillar of public health, warning that any compromise in manufacturing or storage standards during environmental crises could have dire consequences for Ghanaian patients.

Highlighting the current vulnerability of the health sector, PMAG noted that Ghana remains heavily dependent on external sources, importing over 70 percent of its essential medicines. This high level of import reliance makes the safety and quality of locally manufactured products even more paramount to national health security. The association is advocating for increased investment in research and advanced technology to move production beyond basic generics. By enhancing local manufacturing capabilities and implementing strict self-regulation, PMAG aims to reduce the nation's reliance on foreign imports and ensure that all medications produced within the country are safe, effective, and resilient to environmental hazards.

Looking toward the future of the industry, the association is already planning for "PMAG Day 2026," scheduled for July 28, 2026, under the theme "Advancing Ghana's pharmaceutical sovereignty through innovation." This upcoming event is intended to serve as a strategic platform for stakeholders to assess methods for strengthening the local sector and fostering the specialized skills necessary to position Ghana as a preeminent pharmaceutical hub within the West African sub-region. The initiative underscores a long-term commitment to achieving self-sufficiency and driving industrial growth within the healthcare space.

Beyond immediate public health safety, the expansion of the local pharmaceutical industry is expected to yield significant economic dividends. PMAG, which currently represents over 30 companies and employs more than 5,000 people, remains focused on creating a robust industrial value chain. This strategy is designed to not only generate sustainable jobs but also improve the overall affordability of healthcare by providing Ghanaians with easier access to locally produced, high-quality treatments. Through continuous advocacy and stakeholder collaboration, the association continues to champion the production of medications that meet international safety benchmarks.